Abstract
The opioid peptide β-endorphin is released from the pituitary into the blood under physical or emotional stress; its target tissues, however, are unknown1. We report here the specific binding of human β-endorphin to both terminal complexes of human complement: the cytolytic, membrane-derived C5b–9(m) complex and the cytolytically inactive, serum-derived SC5b–9 complex. Binding is through the carboxy-terminus of β-endorphin rather than the amino-terminus, which is implicated in binding to opiate receptors. It is conceivable that the binding of β-endorphin to complement has physiological relevance in the adaptation of the immune system to stress.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amir, S., Brown, Z. W. & Amit, Z. Neurosci. Biobehav. Rev. 4, 77–86 (1980).
Kolb, W. P. & Müller-Eberhard, H. J. J. exp. Med. 141, 724–735 (1975).
Bhakdi, S. & Roth, M. J. Immun. 127, 576–602 (1981).
Tranum-Jensen, J., Bhakdi, S., Bhakdi-Lehnen, B., Bjerrum, O. J. & Speth, V. Scand. J. Immun. 7, 45–56 (1978).
Höllt, V., Przewlocki, R. & Herz, A. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 303, 171–174 (1978).
Guillemin, R., Ling, N. & Vargo, T. Biochem. biophys. Res. Commun. 77, 361–366 (1977).
Bhakdi, S. & Tranum-Jensen, J. Proc. natn. Acad. Sci. U.S.A. 78, 1818–1822 (1981).
Blalock, J. E. & Smith, E. M. Proc. natn. Acad. Sci. U.S.A. 77, 5972–5974 (1980).
Julliard, J. H., Shibasaki, T., Ling, N. & Guillemin, R. Science 208, 183–185 (1980).
Marks, M. J. & Medzihradsky, F. Molec. Pharmac. 10, 837–848 (1974).
Geber, W. F., Lefkowitz, S. S. & Hung, C. Y. Pharmacology 14, 322–329 (1976).
Grube, D. Histochemistry 69, 157–160 (1980).
Lopker, A., Abood, L. G., Hoss, W. & Lionetti, F. J Biochem. Pharmac. 29, 1361–1365 (1980).
McDonough, R. J. et al. J. Immun. 125, 2539–2543 (1980).
Wybran, J., Appelboom, T., Famaey, J. P. & Govaerts, A. J. Immun. 123, 1068–1070 (1979).
Hazum, E., Chang, K. J. & Cuatrecasas, P. Science 205, 1033–1035 (1979).
Colt, E. W. D., Wardlaw, S. L. & Frantz, A. G. Life Sci. 28, 1637–1640 (1981).
Fraioli, F. et al. Experientia 36, 987–989 (1980).
Teschemacher, H., Breidenbach, T., König, A., Luckhardt, M. & Davies-Osterkamp, S. in Endogenous and Exogenous Opiate Agonists and Antagonists (ed. Way, E. L.) 307–308 (Pergamon, New York, 1980).
Akil, H., Watson, S. J., Barchas, J. D. & Li, C. H. Life Sci. 24, 1659–1666 (1979).
Csontos, K. et al. Life Sci. 25, 835–844 (1979).
Svendsen, P. J., Scand. J. Immun. Suppl. 1 69–70 (1973).
Boeynaems, J. M. & Dumont, J. E. Outlines of Receptor Theory (Elsevier, Amsterdam, 1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schweigerer, L., Bhakdi, S. & Teschemacher, H. Specific non-opiate binding sites for human β-endorphin on the terminal complex of human complement. Nature 296, 572–574 (1982). https://doi.org/10.1038/296572a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/296572a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
